Status | Study |
Recruiting |
Study Name: Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt Condition: Advanced Solid and Hematological TP53wt Tumors Date: 2014-05-19 Interventions: Drug: HDM201 Drug: ancillary treatment |
Completed |
Study Name: A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome Condition: Li-Fraumeni Syndrome Date: 2013-11-07 Interventions: Drug: Metformin Treatment will be administered primarily on an outpatient basis. Patients will be instru |
Recruiting |
Study Name: Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients Condition: Polycythemia Vera Essential Thrombocythemia Date: 2013-08-20 Interventions: Procedure: Blood specimen 4 green top tube 40 cc of blood draw |
Active, not recruiting |
Study Name: Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome Condition: Li-Fraumeni Syndrome Date: 2012-11-27 Interventions: Other: Whole body MRI Individu |
Active, not recruiting |
Study Name: Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma Condition: Non-small Cell Lung Cancer Date: 2012-04-06 Interventions: Drug: Surgery combined with rAd-p53 gene therapy |
Recruiting |
Study Name: LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) Condition: Li Fraumeni Syndrome Date: 2011-10-31 Interventions: Other: whole body MRI whole body MRI at inclusion, one and two years |
Recruiting |
Study Name: Clinical and Genetic Studies of Li-Fraumeni Syndrome Condition: Li-Fraumeni Syndrome Neoplasms Date: 2011-09-28 |
Completed |
Study Name: A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) Condition: Ovarian Cancer Date: 2011-05-18 Interventions: Drug: MK-1775 MK-1775 capsules |
Not yet recruiting |
Study Name: rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors Condition: Advanced Malignant Thyroid Tumors Date: 2009-05-12 Interventions: Drug: rAd-p53 gene pre-surgery |
Active, not recruiting |
Study Name: rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors Condition: Advanced Oral and Maxillofacial Malignant Tumors Date: 2009-05-11 Interventions: Drug: p53 gene with surgery pr |